Vincent O'Neill - Executive Vice President, Chief of Product Development and Medical Officer at BioXcel Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Executive Vice President, Chief of Product Development and Medical Officer
Stock Symbol
BTAI on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Vincent O'Neill - trading volume in the past year for BioXcel Therapeutics, Inc.

Holdings reported by Vincent O'Neill for BioXcel Therapeutics, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 3,648 $4.68 K $1.28 Jun 14, 2024 Direct Common Stock
Common Stock 3,524 $4.53 K $1.29 Jun 17, 2024 Direct
Stock Option (Right to Buy) 0 Mar 14, 2023 Direct Common Stock 0

Transactions reported by Vincent O'Neill for BioXcel Therapeutics, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership